�y��vlog

Today, gold-based cancer treatments are gaining global traction, with advancements such as the repurposing of the anti-arthritic drug auranofin, now showing promise in clinical trials for oncology.

Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis.

Because auranofin has already been approved for use in humans, we can save years of expensive development.

"Although auranofin has to date only been tested in animal models of amoebic disease, this means that there is now a potential alternative treatment for individual cases where metronidazole fails to cure the infection or in the event resistance to metronidazole emerge as a clinical problem in the future."

It showed that auranofin was much better than the current treatment, metronidazole, at killing Entamoeba histolytica.